Cannabis May Help Manage Cancer-Related Symptoms and AEs, But Clinical Research Remains a ChallengeSeptember 27th 2021
An expert weighs in on the advantages of cannabis treatment for patients with cancer, and how nurses can help patients navigate the cannabis-oncology space, in spite of certain research limitations.
Cabozantinib Associated With Higher Rates of Certain AEs in Advanced Kidney CancerJune 11th 2021
While cabozantinib exposure was not a predictor of progression-free survival, it was related to high rate of palmar-plantar plantar erythrodysesthesia and diarrhea in patients with advanced renal cell carcinoma who are given frontline cabozantinib plus nivolumab.
Bone-Protecting Agents Reduce Fracture Risk During Prostate Cancer TreatmentJune 9th 2021
Men with asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer who are being treated with radium-223 (Xofigo) plus enzalutamide (Xtandi) can reduce their risk of fractures with the use of bone-protecting agents.
Factors Correspond With Higher Levels of Sleep Disturbance in Patients with GI CancersApril 30th 2021
Factors such as being younger in age, having more comorbidities, and more prior cancer treatments all contribute to higher levels of sleep disturbance in patients with gastrointestinal cancers.
T-DM1 Toxicity Management in Breast CancerApril 5th 2021
Data from the pivotal phase 3 KATHERINE has led to the addition of ado-trastuzumab emtansine to the HER2-positive breast cancer treatment arsenal, but the toxicities associated with the approach must be appropriately managed so that patients can continue to receive it.
Patient Perceptions, Other Factors Linked to Fear of RecurrenceFebruary 19th 2021
Fear of cancer recurrence is a common plight for people after they have completed cancer treatment, and recent research analyzed which patient characteristics were associated with higher rates of fear of recurrence.
Mental Health Screening Is Needed in Blood Cancer SpaceDecember 26th 2020
Data from a recent analysis demonstrated that more than one in five people experienced depression or anxiety, either before or not long after receiving a blood cancer diagnosis, highlighting the need for further mental health screening in these individuals.
Managing GI AEs in Metastatic Breast CancerDecember 15th 2020
Gastrointestinal (GI) adverse events (AEs) that occurred in patients with metastatic breast cancer who were treated with oral paclitaxel and encequidar can be managed by the use of 5- HT3 inhibitors and early intervention with loperamide, according to research presented at the 2020 San Antonio Breast Cancer Symposium.
CAR T-Cell Therapy Improves Blood Cancer, But Toxicities Are Still ConcerningNovember 29th 2020
Following the approvals of tisagenlecleucel (tisa-cel; Kymriah) and axicabtagene ciloleucel (axi-cel; Yescarta), several research efforts have been dedicated to the development and exploration of CAR T-cell therapies in the realm of leukemias and lymphomas, according to Olalekan O. Oluwole, MBBS, MD, who added that although this modality has moved the needle forward, this approach is not without toxicity.
Chemotherapy-Induced Neutropenia: Plinabulin/Pegfilgrastim Combo May HelpNovember 21st 2020
The combination of plinabulin and pegfilgrastim (Neulasta) showed a statistically significant improvement in the rate of prevention of grade 4 neutropenia versus pegfilgrastim alone in patients with cancer undergoing chemotherapy.
Start Sexual Health Discussions Early On, Says ExpertOctober 10th 2020
Maintaining sexual function is often low on the list of priorities for a woman recently diagnosed with a gynecologic cancer, but raising the subject early in her treatment course may make the patient more willing to engage in a discussion as her care progresses, according to Don S. Dizon, MD, who specializes in survivorship issues.